Urological oncology, prostate cancer, testicular cancer, renal cancer, bladder and urothelial tract cancer. Metastatic castrate resistant prostate cancer. Oligometastic disease.
Urological oncology, prostate cancer, testicular cancer, renal cancer, bladder and urothelial tract cancer. Metastatic castrate-resistant prostate cancer. Oligometastic disease.
- American Society of Clinical Oncologists.
- American Brachytherapy Society
- European Society for Therapeutic Radiology and Oncology.
- European Association of Urology.
- Royal College of Radiologists.
- Royal College of Physicians.
- British Photodermatology Group.
- Royal Pharmaceutical Society.
- British Medical Association
Current NHS position
Consultant Clinical Oncologist, Royal Berkshire Hospital, Reading, Berkshire.
1989 - St Mary's Hospital Medical School, London.
Dr Rogers has been a Consultant Clinical Oncologist at the Royal Berkshire NHS Foundation Trust since 1999, and a previous Training Program Director for Clinical Oncology with the Oxford Deanery and is a regional advisor in Clinical Oncology for the Royal College of Radiologists. Dr Rogers graduated from St Mary’s Hospital Medical School, London and went on to complete his general medical training in London followed by seven years oncology training at St Bartholomew’s, Mount Vernon, The Middlesex, and The Royal Free Hospitals in London.
ASCO merit award for research in radiosensitivity 1999
Dr Rogers work in Prostate Brachytherapy work has won prizes at the British Uro-Oncology Group 2010 and the UK and Ireland Prostate Brachytherapy Meeting 2017.
Principle Investigator for national trials in prostate cancer, testicular cancer, renal cancer and genetics.